Hypoglaucine A

Hypoglaucin A is a CXCR3 antagonist with an IC50 of 0.47 μM. Hypoglaucin A can be used for the research of inflammation[1].

93528-39-3

12352005

CXCR

GPCR/G Protein; Immunology/Inflammation

COVID-19-immunoregulation

Inflammation/Immunology

C[C@@]12[C@]3([H])[C@](O[C@]4(CC[C@@H](CO4)C)[C@H]3C)([H])C[C@@]1([H])[C@@]5([H])[C@]([C@@]6(C(C[C@H](CC6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)=CC5)C)([H])CC2

C45H72O16

869.04

[1]Ondeykal JG, et al. Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol Divers. 2005;9 (1-3) :123-9.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N16578/

Natural Products

No Development Reported

CXCR3